NEW YORK, November 25, 2016 /PRNewswire/ -- Persistence Market Research (PMR) delivers key insights on the global animal parasiticides market in its published report, titled "Global Market Study on Animal Parasiticides: Pharmacies and Drug Stores Distribution Channel Segment Expected to Register High Revenue Growth Through 2026." In terms of revenue, the global animal parasiticides market is estimated to register a promising CAGR of 5.9% over the forecast period, owing to numerous factors, about which PMR offers thorough insights and forecasts in this report. The global animal parasiticides market registered a value of US$ 6,976.2 Mn in 2015. (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO ) The prime factors powering the demand for animal parasiticides are increasing awareness about animal healthcare, increasing demand of animal derived food products, growing concern about foodborne diseases and zoonotic diseases, growth in adoption of companion animals and increase in animal healthcare expenditure. However, a growing preference for vegetarian food and diet and a stringent approval process for animal parasiticides coupled with restrictions on the use of parasiticides in food producing animals are the restraints affecting the global animal parasiticides market. A key trend defining the market is that larger players are focused towards enhancing their geographical presence and expanding their customer base by entering into strategic mergers and acquisitions. Furthermore, huge investment from government organizations and private players for research and development activities is also a key trend of global animal parasiticides market. View Report Overview and Research Methodology@http://www.persistencemarketresearch.com/market-research/animal-parasiticide-market.asp The market is segmented based on product type, animal type, distribution channel and region. Based on product type, the market is sub-segmented into Ectoparasiticides, Endoparasiticides and Endectocides. Among the product type segment, Endoparasiticides segment is expected to exhibit the highest revenue growth over the forecast period. The Endoparasiticides product type segment is expected to register a significant CAGR of 5.9% during the forecast period in terms of value. The Ectoparasiticides segment is projected to exhibit a CAGR of 5.7% over the forecast period in terms of value.